title: Defining and scoring response to IFN-β in multiple sclerosis.
abstract: The advent of a large number of new therapies for multiple sclerosis (MS) warrants the development of tools that enable selection of the best treatment option for each new patient with MS. Evidence from clinical trials clearly supports the efficacy of IFN-β for the treatment of MS, but few factors that predict a response to this drug in individual patients have emerged. This deficit might be due, at least in part, to the lack of a standardized definition of the clinical outcomes that signify improvement or worsening of the disease. MRI markers and clinical relapses have been the most widely studied short-term factors to predict long-term response to IFN-β, although the results are conflicting. Recently, integrated strategies combining MRI and clinical markers in scoring systems have provided a potentially useful approach for the management of patients with MS. In this Review, we focus on the many definitions of clinical response to IFN-β and explore the markers that can be used to predict this response. We also highlight advantages and limitations of the existing scoring systems in light of future expansion of these models to biological markers and to other classes of emerging therapies for MS.
authors.affiliation: Department of Health Sciences (DISSAL), University of Genoa, Via Pastore 1, Genoa 16132, Italy. mariapia.sormani@ unige.it
authors.forename: Maria Pia
authors.initials: MP
authors.lastname: Sormani
authors.forename: Nicola
authors.initials: N
authors.lastname: De Stefano
mesh_terms: D054316:Biomarkers, Pharmacological; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D054316:Biomarkers, Pharmacological; D016899:Interferon-beta
references.citation: Curr Med Res Opin. 2009 Oct;25(10):2459-70
references.pmid: 19678753
references.citation: Neurology. 1993 Apr;43(4):655-61
references.pmid: 8469318
references.citation: Ann Neurol. 2006 Feb;59(2):344-52
references.pmid: 16437558
references.citation: Neurol Res Int. 2011;2011:195831
references.pmid: 22242202
references.citation: Lancet. 2013 Jun 22;381(9884):2167-75
references.pmid: 23562009
references.citation: PLoS One. 2008 Apr 02;3(4):e1927
references.pmid: 18382694
references.citation: Nat Rev Neurol. 2009 Oct;5(10):553-60
references.pmid: 19794514
references.citation: J Neuroimmunol. 2002 Sep;130(1-2):194-201
references.pmid: 12225902
references.citation: Ann Neurol. 1996 Mar;39(3):285-94
references.pmid: 8602746
references.citation: Mult Scler. 2013 Apr;19(5):605-12
references.pmid: 23012253
references.citation: Brain. 1988 Aug;111 ( Pt 4):927-39
references.pmid: 3401689
references.citation: Mult Scler. 2009 Jun;15(6):728-34
references.pmid: 19482863
references.citation: Nat Med. 2010 Apr;16(4):406-12
references.pmid: 20348925
references.citation: J Neurol Sci. 2007 Jul 15;258(1-2):52-9
references.pmid: 17467740
references.citation: Mult Scler. 2006 Jun;12(3):281-6
references.pmid: 16764340
references.citation: Ann Neurol. 2004 Oct;56(4):548-55
references.pmid: 15389896
references.citation: Ann Neurol. 2003 Jun;53(6):718-24
references.pmid: 12783417
references.citation: Mult Scler. 2010 Dec;16(12):1414-21
references.pmid: 20810517
references.citation: N Engl J Med. 2012 Sep 20;367(12):1098-107
references.pmid: 22992073
references.citation: Ann Neurol. 1983 Mar;13(3):227-31
references.pmid: 6847134
references.citation: Neurology. 2012 Nov 6;79(19):1942-3
references.pmid: 23035058
references.citation: Lancet. 2012 Nov 24;380(9856):1819-28
references.pmid: 23122652
references.citation: Stat Med. 1989 Apr;8(4):431-40
references.pmid: 2727467
references.citation: J Neurol. 1997 Feb;244(2):76-84
references.pmid: 9120500
references.citation: Nat Rev Neurol. 2009 May;5(5):256-66
references.pmid: 19488083
references.citation: Mult Scler. 2008 Nov;14(9):1234-41
references.pmid: 18632774
references.citation: Nat Rev Neurol. 2011 Apr;7(4):221-8
references.pmid: 21364522
references.citation: N Engl J Med. 2010 Feb 4;362(5):402-15
references.pmid: 20089954
references.citation: J Neuroimmunol. 2007 Jul;187(1-2):1-8
references.pmid: 17400297
references.citation: Mult Scler. 2011 Sep;17(9):1113-21
references.pmid: 21613336
references.citation: J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51
references.pmid: 17986500
references.citation: Neurology. 1983 Nov;33(11):1444-52
references.pmid: 6685237
references.citation: Neuropsychiatr Dis Treat. 2012;8:465-73
references.pmid: 23118540
references.citation: N Engl J Med. 2006 Mar 2;354(9):899-910
references.pmid: 16510744
references.citation: Mult Scler. 2011 May;17(5):541-9
references.pmid: 21148262
references.citation: Neurotherapeutics. 2013 Jan;10(1):1
references.pmid: 23238890
references.citation: JAMA Neurol. 2013 Aug;70(8):1017-21
references.pmid: 23732754
references.citation: Ther Adv Neurol Disord. 2012 Jul;5(4):205-20
references.pmid: 22783370
references.citation: Mult Scler. 2013 Aug;19(9):1246-7
references.pmid: 23549435
references.citation: Ann Neurol. 2002 Oct;52(4):400-6
references.pmid: 12325067
references.citation: Lancet. 2012 Nov 24;380(9856):1829-39
references.pmid: 23122650
references.citation: PLoS One. 2012;7(11):e50101
references.pmid: 23166826
references.citation: J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):282-7
references.pmid: 22193561
references.citation: Neurology. 2003 Jul 22;61(2):184-9
references.pmid: 12874396
references.citation: Ann Neurol. 2013 Jan;73(1):95-103
references.pmid: 23378325
references.citation: Nat Rev Neurol. 2011 Dec 06;8(1):13-21
references.pmid: 22143362
references.citation: Lancet. 2002 Apr 6;359(9313):1221-31
references.pmid: 11955556
references.citation: Neurology. 2002 Feb 12;58(3):417-21
references.pmid: 11839841
references.citation: J Neurol. 2006 Mar;253(3):287-93
references.pmid: 16151600
references.citation: J Neurol. 2008 Apr;255(4):480-7
references.pmid: 18004635
references.citation: Can J Neurol Sci. 2013 May;40(3):307-23
references.pmid: 23603165
references.citation: Neurology. 2003 May 13;60(9):1462-6
references.pmid: 12743232
references.citation: Neurology. 2012 Aug 7;79(6):531-7
references.pmid: 22573631
references.citation: Neurology. 1993 Apr;43(4):662-7
references.pmid: 8469319
references.citation: Neuroepidemiology. 2008;31(3):150-6
references.pmid: 18716412
references.citation: N Engl J Med. 2011 Oct 6;365(14):1293-303
references.pmid: 21991951
references.citation: Neurotherapeutics. 2013 Jan;10(1):2-18
references.pmid: 23264098
references.citation: Mult Scler. 2008 May;14(4):479-84
references.pmid: 18562504
references.citation: Neurology. 2011 Nov 1;77(18):1684-90
references.pmid: 21975200
references.citation: N Engl J Med. 2012 Mar 15;366(11):1000-9
references.pmid: 22417253
references.citation: N Engl J Med. 2012 Sep 20;367(12):1087-97
references.pmid: 22992072
references.citation: N Engl J Med. 2010 Feb 4;362(5):387-401
references.pmid: 20089952
references.citation: Mult Scler. 2006 Dec;12(6):826-9
references.pmid: 17263014
references.citation: Lancet. 1998 Nov 7;352(9139):1498-504
references.pmid: 9820297
references.citation: Eur J Neurol. 2009 Nov;16(11):1202-9
references.pmid: 19538207
references.citation: Eur J Neurol. 2013 Jul;20(7):1060-7
references.pmid: 23425504
references.citation: Neurology. 2012 Nov 6;79(19):2000-3
references.pmid: 23035065
references.citation: Neurotherapeutics. 2013 Jan;10(1):19-28
references.pmid: 23307290
references.citation: Neurology. 2006 Mar 28;66(6):894-900
references.pmid: 16567708
references.citation: Lancet Neurol. 2012 Jan;11(1):33-41
references.pmid: 22146409